SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (NASDAQ:TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with other life science companies, announced today that Charles Theuer, M.D., Ph.D., President and Chief Executive Officer, will participate at the following upcoming investor conferences and provide a company overview:
- H.C. Wainwright 25th Annual Global Investment Conference – Available on demand beginning on September 11th at 7:00am EDT
- RW Baird 2023 Global Healthcare Conference – September 12th at 4:20pm EDT
To access the H.C. Wainwright conference presentation, please visit the "Events and Presentations" page within the "Investors" section of the ...